{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:57:24Z","timestamp":1792515444795,"version":"4.5.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,2]]},"abstract":"<jats:p>\n                    As an acknowledged inflammatory cytokine, CXCL17 is also participated in various malignancies, including pancreatic ductal adenocarcinoma, lung cancer, colon cancer, and thyroid carcinoma. Nevertheless, it is still unclear whether CXCL17 is correlated with tumorigenesis and advancement of cervical cancer. The aim of this study was to study the clinical significance of CXCL17 in cervical cancer patients and its associations with epithelial-to-mesenchymal transition (EMT) markers. The present study analyzed the CXCL17 expression pattern in cervical cancer and investigated its correlation with clinicopathological parameters in 80 cervical cancer cases. Furthermore, the correlation between CXCL17 and EMT markers were evaluated. The results showed CXCL17 expression was positive in 67.50% (54\/80) cases. Our results revealed CXCL17 expression was significantly correlated with lymph node metastasis and clinical stage (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). GPR35 expression was significantly enhanced in cervical cancer tissues. More importantly, CXCL17 expression was correlated with snail or vimentin expression. Simultaneously, CXCL17 expression had a negative correlation with E-cadherin expression. These results demonstrated the close correlation between CXCL17 expression and EMT markers. Our findings revealed that CXCL17 promotes advancement of cervical cancer via influence of some critical EMT markers.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000046178","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:02:15Z","timestamp":1767711735000},"page":"e46178","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Clinical significance of CXCL17 in cervical cancer"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7191-4609","authenticated-orcid":false,"given":"Jingming","family":"Zhai","sequence":"first","affiliation":[{"name":"Department of General Surgery, The First Affiliated Hospital and College of Clinical Medicine, Henan University of Science and Technology, Luoyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianshu","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Affiliated Hospital and College of Clinical Medicine, Henan University of Science and Technology, Luoyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"An","sequence":"additional","affiliation":[{"name":"Health Management Center, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Affiliated Hospital and College of Clinical Medicine, Henan University of Science and Technology, Luoyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Affiliated Hospital and College of Clinical Medicine, Henan University of Science and Technology, Luoyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longhui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Affiliated Hospital and College of Clinical Medicine, Henan University of Science and Technology, Luoyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Like","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Affiliated Hospital and College of Clinical Medicine, Henan University of Science and Technology, Luoyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujia","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Affiliated Hospital and College of Clinical Medicine, Henan University of Science and Technology, Luoyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260218","doi-asserted-by":"crossref","first-page":"235","DOI":"10.31083\/j.ceog5110235","article-title":"Strategic approaches in management of early-stage cervical cancer: a comprehensive editorial.","volume":"51","author":"Golia D\u2019Aug\u00e8","year":"2024","journal-title":"Clin Exp Obstet Gynecol"},{"key":"R2-20260218","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14656566.2023.2298329","article-title":"Pharmacotherapy for the treatment of recurrent cervical cancer: an update of the literature.","volume":"25","author":"D\u2019Oria","year":"2024","journal-title":"Expert Opin Pharmacother"},{"key":"R3-20260218","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1188\/16.CJON.79-83","article-title":"Cervical cancer screening in developing countries: using visual inspection methods.","volume":"20","author":"Lee","year":"2016","journal-title":"Clin J Oncol Nurs"},{"key":"R4-20260218","first-page":"241","article-title":"Incidence and mortality of cervical cancer in China.","volume":"40","author":"Gu","year":"2018","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"R5-20260218","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/cbin.11846","article-title":"A comprehensive review of chemokine CXC17 (VCC1) in cancer, infection, and inflammation.","volume":"46","author":"Gowhari Shabgah","year":"2022","journal-title":"Cell Biol Int"},{"key":"R6-20260218","doi-asserted-by":"crossref","first-page":"e12965","DOI":"10.1111\/sji.12965","article-title":"Mucosal chemokine CXCL17: What is known and not known.","volume":"93","author":"Xiao","year":"2021","journal-title":"Scand J Immunol"},{"key":"R7-20260218","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.3892\/ol.2020.11819","article-title":"Prognostic value of CXCL17 and CXCR8 expression in patients with colon cancer.","volume":"20","author":"Yao","year":"2020","journal-title":"Oncol Lett"},{"key":"R8-20260218","doi-asserted-by":"crossref","first-page":"e1665460","DOI":"10.1080\/2162402X.2019.1665460","article-title":"Tumor cell expression of B7-H4 correlates with higher frequencies of tumor-infiltrating APCs and higher CXCL17 expression in human epithelial ovarian cancer.","volume":"8","author":"MacGregor","year":"2019","journal-title":"Oncoimmunology"},{"key":"R9-20260218","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.bbrc.2017.09.113","article-title":"The role and clinical significance of the CXCL17-CXCR8 (GPR35) axis in breast cancer.","volume":"493","author":"Guo","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"R10-20260218","doi-asserted-by":"crossref","first-page":"e44080","DOI":"10.1371\/journal.pone.0044080","article-title":"CXCL17 expression by tumor cells recruits CD11b+Gr1 high F4\/80- cells and promotes tumor progression.","volume":"7","author":"Matsui","year":"2012","journal-title":"PLoS One"},{"key":"R11-20260218","doi-asserted-by":"crossref","first-page":"155436","DOI":"10.1016\/j.cyto.2021.155436","article-title":"MiR-325-3p mediate the CXCL17\/CXCR8 axis to regulate angiogenesis in hepatocellular carcinoma.","volume":"141","author":"Li","year":"2021","journal-title":"Cytokine"},{"key":"R12-20260218","doi-asserted-by":"crossref","first-page":"711402","DOI":"10.3389\/fonc.2021.711402","article-title":"Prognostic biomarkers and immunotherapeutic targets among CXC chemokines in pancreatic adenocarcinoma.","volume":"11","author":"Huang","year":"2021","journal-title":"Front Oncol"},{"key":"R13-20260218","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/CAD.0000000000001280","article-title":"Expression and clinical significance of CXCL17 and GPR35 in endometrial carcinoma.","volume":"33","author":"Hao","year":"2022","journal-title":"Anticancer Drugs"},{"key":"R14-20260218","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.gene.2018.12.043","article-title":"CXCL17 promotes cell metastasis and inhibits autophagy via the LKB1-AMPK pathway in hepatocellular carcinoma.","volume":"690","author":"Wang","year":"2019","journal-title":"Gene"},{"key":"R15-20260218","doi-asserted-by":"crossref","first-page":"1306273","DOI":"10.3389\/fphar.2024.1306273","article-title":"Over-expression of CXCL17 increases migration and invasion of A549 lung adenocarcinoma cells.","volume":"15","author":"Koni","year":"2024","journal-title":"Front Pharmacol"},{"key":"R16-20260218","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12943-024-01954-8","article-title":"Resistance of HNSCC cell models to pan-FGFR inhibition depends on the EMT phenotype associating with clinical outcome.","volume":"23","author":"Broghammer","year":"2024","journal-title":"Mol Cancer"},{"key":"R17-20260218","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3897\/folmed.65.e84132","article-title":"Expression of snail and twist compared with clinical and pathological parameters in patients with gastric cancer.","volume":"65","author":"Poryazova","year":"2023","journal-title":"Folia Med (Plovdiv)"},{"key":"R18-20260218","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10555-016-9648-7","article-title":"EMT, cell plasticity and metastasis.","volume":"35","author":"Chaffer","year":"2016","journal-title":"Cancer Metastasis Rev"},{"key":"R19-20260218","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/1878-0261.12083","article-title":"EMT and MET: necessary or permissive for metastasis?","volume":"11","author":"Jolly","year":"2017","journal-title":"Mol Oncol"},{"key":"R20-20260218","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2174\/15680096113136660102","article-title":"The role of snail in EMT and tumorigenesis.","volume":"13","author":"Wang","year":"2013","journal-title":"Curr Cancer Drug Targets"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046178","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:02:02Z","timestamp":1771434122000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046178","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"2024-06-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}